» Articles » PMID: 37276482

Dementia Care Is Widespread In US Nursing Homes; Facilities With The Most Dementia Patients May Offer Better Care

Overview
Specialty Health Services
Date 2023 Jun 5
PMID 37276482
Authors
Affiliations
Soon will be listed here.
Abstract

More than three million US nursing home residents were diagnosed with Alzheimer's disease and related dementias (ADRD) between 2017 and 2019. This number is expected to increase as the population ages and ADRD prevalence increases. People with ADRD require specialized care from trained staff. This study addressed two questions: Are residents with ADRD concentrated in nursing homes where they are the majority? If not, what are the implications for their quality of care and life? We answered the first question by determining the ADRD census for each nursing home in the country during the period 2017-19. Using the Minimum Data Set and Medicare claims, we compared characteristics of nursing homes with high and low ADRD census along several dimensions, including staffing, resident outcomes, and resident characteristics. We found that residents with ADRD were dispersed throughout all nursing homes, with fewer than half residing in nursing homes where residents with ADRD accounted for 60-90 percent of the census. Furthermore, only facilities exceeding 90 percent of residents with ADRD seemed to offer better care. These findings raise concerns about the quality of care and life for the majority of residents with ADRD, suggesting that current National Institutes of Health dementia research initiatives and the Biden administration's policies to improve nursing home care should be coordinated.

Citing Articles

Missing incidents and the risk of harm in persons living with dementia reported to the Swedish police- A nationwide retrospective registry study.

Larsson M, Arestedt K, Svensson A, Andersson H, Wolmesjo M BMC Geriatr. 2025; 25(1):153.

PMID: 40045223 PMC: 11883908. DOI: 10.1186/s12877-025-05809-9.


What happens behind closed doors? Investigating care practices in nursing home and assisted living memory care units.

Elliot A, Bowblis J, Nelson I, Menne H Health Aff Sch. 2025; 3(2):qxaf026.

PMID: 40040650 PMC: 11878529. DOI: 10.1093/haschl/qxaf026.


How Nursing Home Nurses Who Care for Residents With Dementia Experience the Moral Distress? A Phenomenography Study.

Kim E, Lee Y, Chang S Nurs Open. 2025; 12(3):e70171.

PMID: 40022422 PMC: 11870852. DOI: 10.1002/nop2.70171.


Educational needs of direct care workers in long-term care facilities providing mealtime assistance to older adults with dementia.

Jung D, Park J, Choi E, Yoo L, Kim K, Cho S BMC Geriatr. 2024; 24(1):808.

PMID: 39363169 PMC: 11451254. DOI: 10.1186/s12877-024-05368-5.


Medicare Advantage enrollment and outcomes of post-acute nursing home care among patients with dementia.

Kim D, Meyers D, Keohane L, Varma H, Achola E, Trivedi A Health Aff Sch. 2024; 2(6):qxae084.

PMID: 38934015 PMC: 11199989. DOI: 10.1093/haschl/qxae084.


References
1.
Konetzka R, White E, Pralea A, Grabowski D, Mor V . A systematic review of long-term care facility characteristics associated with COVID-19 outcomes. J Am Geriatr Soc. 2021; 69(10):2766-2777. PMC: 8631348. DOI: 10.1111/jgs.17434. View

2.
Mukamel D, Saliba D, Ladd H, Konetzka R . Association of Staffing Instability With Quality of Nursing Home Care. JAMA Netw Open. 2023; 6(1):e2250389. PMC: 9856742. DOI: 10.1001/jamanetworkopen.2022.50389. View

3.
Lai C, Yeung J, Mok V, Chi I . Special care units for dementia individuals with behavioural problems. Cochrane Database Syst Rev. 2009; (4):CD006470. DOI: 10.1002/14651858.CD006470.pub2. View

4.
Liu N, Sun J, Wang X, Zhao M, Huang Q, Li H . The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2020; 78(4):1775-1782. DOI: 10.3233/JAD-201016. View

5.
Gilstrap L, Zhou W, Alsan M, Nanda A, Skinner J . Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic. JAMA Neurol. 2022; 79(4):342-348. PMC: 8886452. DOI: 10.1001/jamaneurol.2022.0010. View